Finally, both synthetic GHCer and the GHCer from tumor-secreted extracellular vesicles (EVs) were validated to compete with PLCβ1 for complexing with TRAX and induce angiogenesis in vitro and in vivo. This evidence concerns the gene PLCB1 and neoplasm.